top of page
Efficient selection of tumor associated neoantigens in the design of personalized cancer vaccines
Michael Princiotta, CSO EpiVax Therapeutics
International Society for Vaccines (ISV) Annual Meeting
September 2021
©2023 by EpiVax Therapeutics, Inc.
bottom of page